Site Search
You searched for "hepatitis D"
-
Three New Studies Help Clarify Optimal Use of Combination Therapy in Chronic Hepatitis B Patients
Three new studies presented today at the International Liver Congress 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB). "Together these ground-breaking data will go a long way to influencing future CHB treatment guidelines," said EASL's Educational Councillor Professor Cihan Yurdaydin from the Department of Gastroenterology, University of Ankara, Turkey. In the first study , CHB patients who had failed on prior long-term exposure to one of the nucleoside analogue (NUC) antivirals demonstrated high rates of complete response and HBsAg loss when prescribed a sequential combination of peginterferon and NUC. In the second study , adding peginterferon to the nucleoside analogue entecavir was shown to enhance response rates and viral decline in HBeAg-positive CHB patients with compensated liver-disease, was generally safe and well tolerated, and may facilitate the discontinuation of entecavir. Finally, data from a third study suggested that adding on a NUC for six weeks to PegIFNalfa-2a does not enhance treatment response, with no increase in HBeAg seroconversion rates beyond that achieved by PegIFNα-2a alone after 24 weeks follow-up. Continue reading more...
http://www.hepb.org/blog/three-new-studies-help-clarify-optimal-use-of-combination-therapy-in-chronic-hepatitis-b-patients/ -
Inexpensive Test Could Reveal Liver Cancer Risk
Could an inexpensive test, used in conjunction with current, traditional HCC testing help reveal one's liver cancer risk? Research for the V-chip is described in an article published in this week's Health Canal. Scientists from the Houston Methodist Research Institute and the University of Texas M.D. Anderson Cancer Center will receive about $2.1 million from the National Cancer Institute to learn whether a small, low-cost device can help assess a person's risk of developing a common form of liver cancer. The four-year project is based on technology previously developed by Houston Methodist nanomedicine faculty member Lidong Qin, Ph.D., who is the new project's principal investigator. Qin's "V-Chip," or volumetric bar-chart chip, will be used to detect biomarkers for hepatocellular carcinoma (HCC), the most common cause of liver cancer. The device only requires a drop of blood from a finger prick. The V-Chip allows the testing of up to 50 different molecules in a blood or urine sample. "Most of the burden of HCC is borne by people who have low income, with the highest incidence rates reported in regions of the world where infection with hepatitis B virus is endemic," Qin said. "Developing an accurate and low-cost technology that assesses the risk of cancer could make a big difference to people who ordinarily can't afford expensive tests." M.D. Anderson Department of Epidemiology Chair Xifeng Wu is the project's co-principal investigator. Qin and Wu will see whether the V-Chip accurately detects HCC biomarkers. The researchers will also determine which combination of these biomarkers proves most predictive of disease. Among the biomarkers the researchers will look at are antigens of hepatitis viruses B and C, aflatoxin (a fungal toxin that at high doses is associated with cancer risk), and metabolic indicators of alcohol consumption, obesity, diabetes, and iron overdose. Tests of the V-chip will not replace traditional testing methods, but rather be
http://www.hepb.org/blog/inexpensive-test-could-reveal-liver-cancer-risk/ -
Kudos to HBF’s Blog Voted as a “Sexual Health Top 10, Must Read Blog”
The team at Health Express has voted HBF’s blog as one of the “Must Read Blogs of 2013 – Sexual Health Top 10!” HealthExpress.co.uk is an online clinic that provides support, advice and treatment for common medical conditions that patients do not always feel comfortable talking about. You can take a look at their recommended Top 10 blogs and learn more about them at healthexpress.co.uk. The accolades from the HealthExpress team are a great opportunity to review transmission of the hepatitis B virus. HBV is transmitted through infected blood and body fluids. This includes direct blood-to-blood contact, unprotected sex, unsterile needles, and from an infected woman to her newborn baby at birth. Sharing sharp, personal items that may have trace amounts of blood on them such a razors, toothbrushes, nail clippers and body jewelry including earrings, can also spread the virus. Remember that the HBV virus may live up to a week on a surface resulting in possible transmission through direct blood-to-blood contact. This is why close, household contacts or family members are at greater risk of infection if one or more members are living with HBV. Don’t forget to be sure your tattoo or piercing experience is safe and that the parlor carefully follows infection control practices. Hepatitis B is also 50-100 times more infectious than the HIV virus. Hepatitis B is also a sexually transmitted disease and is spread through infected semen, vaginal fluids and any blood that may be exchanged as part of a sexual practice – most often through sexual intercourse. In the United States, sexual transmission is the most common mode of HBV transmission and is responsible for 2/3 of acute HBV infections. A common question is “what about oral sex?” In general, oral sex would be considered less risky, but any kind of intimate sharing that may result in the exchange of bodily fluids will present some degree of risk. So how can you prevent hepatitis B transmission between
http://www.hepb.org/blog/kudos-to-hbfs-blog-voted-as-a-sexual-health-top-10-must-read-blog/ -
Hepatitis B Awareness Month at HBF
… the Rocky Steps with us! All participants get a “B a hero” t-shirt and a cape. City Councilman David Oh will present a city council resolution, and a surprise performance will take place when we reach the middle level of the steps. Saturday, June 1 Independence Dragon Boat Regatta 8am-5pm @ Schuylkill River (Kelly Drive, near St. John’s Boathouse) Come cheer for team Philadelphia Hep B Heroes as well paddle our way to victory! The regatta is a family event with lots of entertainment such as cultural performances, rock climbing, and of course the exciting dragon boat races. So visit the Hepatitis B Foundation/Team Philadelphia Hep B Heroes tent for some snacks and cheer for our heroes. Additional event: Saturday, May 11 Hepatitis B Screening & Mini Health Fair 10am-1pm @ AmeriCare Pharmacy (600 Washington Avenue, Unit 18E, Philadelphia) May Hepatitis Awareness Month would be incomplete without a screening event. In collaboration with the Jefferson Medical College APAMSA medical students and the AmeriCare Pharmacy, we will be providing free hepatitis B screening tests for those who were born in Asia or whose parents were born in Asia. Additional service such as blood pressure and blood glucose measurements will also be available at this event.
http://www.hepb.org/blog/hepatitis-b-awareness-month-at-hbf/ -
Sheree Martin Retires from the Hepatitis B Information and Support List
After 13 Years, our Mammablondie has retired as a listowner of the Hepatitis B Information and Support List. Sheree Martin has been List Mom to thousands of hepBers who have come to us from all over the world. Like a true mother, she was quick to give hugs, the cyber kind, just when we needed them most. And when we squabbled, she was there to call "time out". As for the "information" component of our list, Sheree has contributed more than anyone else. She has spent countless hours scanning the Internet daily for HBV research and news. The result of her efforts is our Hepatitis B Research List. For those wishing for information only, you can select send a blank email to HBV_Research-on@mail-list.com For a number of years the PKIDS organization hired her to do the same thing for them, provide them with daily bulletins about kids' infectious diseases. Sheree donated the money she earned to our listserv in order to cover miscellaneous expenses. In the beginning days of the List, John Kirk and I recognized immediately what a gem Sheree was, and we invited her to join us as a third listowner. She was smart, she was a nurse, she had IT skills, she was a good writer, and she knew how to referee when the two male egos would wrestle. Sheree lives in the same small town where she grew up, on the edge of the Appalachian Mountains. She's proud of what she calls her hillbilly roots. We all got to know and love Sheree's mother, Yvonne, when she accompanied Sheree to the Hepatitis B Foundation's patient conferences. Not only did Yvonne have HBV, but in 1999, Sheree's only sibling, Mike, died of liver cancer associated with HBV. Fighting HBV was a very personal battle for Sheree. We'll need two people to fill Sheree's shoes on the List. Yvonne Drazic (Australia) will be our new listowner, and Christine Kukka (Maine) will take over the Research List. At home in that picturesque country village, Sheree will have more time to do what she loves most-- being a
http://www.hepb.org/blog/sheree-martin-is-retiring-from-the-hepatitis-b-information-and-support-list/
